Joseph C. Cappelleri

23.8k total citations · 6 hit papers
496 papers, 17.5k citations indexed

About

Joseph C. Cappelleri is a scholar working on Psychiatry and Mental health, Rheumatology and Economics and Econometrics. According to data from OpenAlex, Joseph C. Cappelleri has authored 496 papers receiving a total of 17.5k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Psychiatry and Mental health, 82 papers in Rheumatology and 82 papers in Economics and Econometrics. Recurrent topics in Joseph C. Cappelleri's work include Health Systems, Economic Evaluations, Quality of Life (69 papers), Musculoskeletal pain and rehabilitation (55 papers) and Dermatology and Skin Diseases (50 papers). Joseph C. Cappelleri is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (69 papers), Musculoskeletal pain and rehabilitation (55 papers) and Dermatology and Skin Diseases (50 papers). Joseph C. Cappelleri collaborates with scholars based in United States, United Kingdom and Canada. Joseph C. Cappelleri's co-authors include Andrew G. Bushmakin, R. Rosen, L.P. Chandler, Peter J. Weiden, David B. Allison, Moonseong Heo, Ian H. Osterloh, Raymond C. Rosen, Alesia Sadosky and Robert A. Gerber and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Joseph C. Cappelleri

460 papers receiving 16.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis

1999 1.9k citations Joseph C. Cappelleri et al. profile →
Diagnostic evaluation of the erectile function domain of the international index of erectile function

1999 877 citations Joseph C. Cappelleri et al. profile →
Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1

2011 825 citations Joseph C. Cappelleri et al. profile →
The International Index of Erectile Function (IIEF): a state-of-the-science review

2002 806 citations Joseph C. Cappelleri et al. profile →
Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2

2011 604 citations Joseph C. Cappelleri et al. profile →
Overview of Classical Test Theory and Item Response Theory for the Quantitative Assessment of Items in Developing Patient-Reported Outcomes Measures

2014 400 citations Joseph C. Cappelleri et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph C. Cappelleri United States	58	5.7k	2.8k	2.4k	2.4k	1.9k	496	17.5k
Marjo‐Riitta Järvelin Finland	87	3.4k 0.6×	2.2k 0.8×	3.7k 1.5×	3.0k 1.3×	1.5k 0.8×	553	26.0k
Truls Østbye United States	73	4.2k 0.7×	1.3k 0.5×	2.1k 0.8×	1.8k 0.7×	1.5k 0.8×	577	20.1k
Keith J. Petrie New Zealand	63	4.0k 0.7×	1.2k 0.4×	1.1k 0.5×	3.1k 1.3×	941 0.5×	266	20.5k
Jakob Bue Bjørner Denmark	53	2.5k 0.4×	1.4k 0.5×	1.0k 0.4×	2.0k 0.8×	1.7k 0.9×	203	15.6k
Dennis A. Revicki United States	88	4.8k 0.8×	884 0.3×	2.6k 1.1×	3.5k 1.5×	4.4k 2.4×	445	31.4k
Carl F. Pieper United States	83	3.9k 0.7×	764 0.3×	5.6k 2.3×	1.6k 0.7×	3.1k 1.6×	440	25.6k
Kristina Sundquist Sweden	74	2.4k 0.4×	1.1k 0.4×	2.3k 0.9×	3.0k 1.2×	2.1k 1.1×	944	24.2k
John B. McKinlay United States	76	8.2k 1.4×	12.4k 4.5×	1.5k 0.6×	2.7k 1.1×	1.2k 0.7×	274	24.9k
Kirsten Ohm Kyvik Denmark	72	1.9k 0.3×	2.3k 0.8×	3.0k 1.2×	651 0.3×	1.5k 0.8×	321	16.3k
Anna Chaimani France	37	2.4k 0.4×	857 0.3×	1.6k 0.7×	1.1k 0.4×	2.5k 1.4×	94	17.1k

Countries citing papers authored by Joseph C. Cappelleri

Since Specialization

Citations

This map shows the geographic impact of Joseph C. Cappelleri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph C. Cappelleri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph C. Cappelleri more than expected).

Fields of papers citing papers by Joseph C. Cappelleri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph C. Cappelleri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph C. Cappelleri. The network helps show where Joseph C. Cappelleri may publish in the future.

Co-authorship network of co-authors of Joseph C. Cappelleri

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph C. Cappelleri. A scholar is included among the top collaborators of Joseph C. Cappelleri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph C. Cappelleri. Joseph C. Cappelleri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jairath, Vipul, Tim Raine, Thomas P. Leahy, et al.. (2025). Matching-adjusted indirect comparisons of efficacy outcomes between etrasimod and ozanimod for moderately to severely active ulcerative colitis. Journal of Comparative Effectiveness Research. 14(4). e240193–e240193.

Eder, Lihi, Pascal Richette, Laura C. Coates, et al.. (2024). Gender Differences in Perceptions of Psoriatic Arthritis Disease Impact, Management, and Physician Interactions: Results from a Global Patient Survey. Rheumatology and Therapy. 11(5). 1115–1134. 2 indexed citations

Hauber, Brett, Kathleen Beusterien, Amy Law, et al.. (2024). A latent class analysis of factors influencing preferences for infant respiratory syncytial virus (RSV) preventives among pregnant people in the United States. Human Vaccines & Immunotherapeutics. 20(1). 2358566–2358566. 8 indexed citations

Mease, Philip J., et al.. (2024). Adherence, Persistence, Healthcare Resource Use, and Costs in Tofacitinib-Treated Patients with Psoriatic Arthritis: Data from Two United States Claims Databases. Advances in Therapy. 41(10). 3850–3867.

Rocque, Gabrielle B., Joanne L. Blum, Yan Ji, et al.. (2024). Abstract PO3-05-11: Enhancing the interpretation of real-world quality of life (QoL) in patients (pts) with hormone receptor positive human epidermal growth factor 2 negative (HR+/HER2−) advanced breast cancer (ABC) enrolled in the POLARIS trial. Cancer Research. 84(9_Supplement). PO3–5.

Peyrin‐Biroulet, Laurent, et al.. (2023). The Impact of the COVID-19 Pandemic on Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient Survey. Advances in Therapy. 41(2). 598–617. 2 indexed citations

Schnitzer, Thomas J., R.L. Robinson, Lars Viktrup, et al.. (2023). Opioids for Osteoarthritis: Cross-Sectional Survey of Patient Perspectives and Satisfaction. Journal of Clinical Medicine. 12(7). 2733–2733. 1 indexed citations

Hlavacek, Patrick, et al.. (2023). A matching-adjusted indirect treatment comparison of elranatamab in patients with triple-class exposed relapsed/refractory multiple myeloma: Comparisons with belantamab mafodotin, selinexor plus dexamethasone, and real-world physician’s choice of treatment.. Journal of Clinical Oncology. 41(16_suppl). e20038–e20038. 1 indexed citations

Fusco, Manuela Di, Xiaowu Sun, Kristen E. Allen, et al.. (2023). Impact of Bivalent BA.4/5 BNT162b2 COVID-19 Vaccine on Acute Symptoms, Quality of Life, Work Productivity and Activity Levels among Symptomatic US Adults Testing Positive for SARS-CoV-2 at a National Retail Pharmacy. Vaccines. 11(11). 1669–1669. 5 indexed citations

10.

LeBlanc, Thomas W., et al.. (2023). A matching-adjusted indirect comparison of the efficacy of elranatamab versus physician’s choice of treatment in patients with triple-class exposed/refractory multiple myeloma. Current Medical Research and Opinion. 40(2). 199–207. 8 indexed citations

11.

Yosipovitch, Gil, Melinda Gooderham, Sonja Ständer, et al.. (2023). Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2. American Journal of Clinical Dermatology. 25(1). 127–138. 7 indexed citations

12.

Silverberg, Jonathan I., Jacob P. Thyssen, Kyle Fahrbach, et al.. (2021). Comparative efficacy and safety of systemic therapies used in moderate‐to‐severe atopic dermatitis: a systematic literature review and network meta‐analysis. Journal of the European Academy of Dermatology and Venereology. 35(9). 1797–1810. 86 indexed citations

13.

Coates, Laura C., Valderílio Feijó Azevedo, Joseph C. Cappelleri, et al.. (2021). Exploring the Quality of Communication Between Patients with Psoriatic Arthritis and Physicians: Results of a Global Online Survey. Rheumatology and Therapy. 8(4). 1741–1758. 5 indexed citations

14.

Perrot, Serge, Michael J. Doane, Dena H. Jaffe, et al.. (2021). Burden of chronic low back pain: Association with pain severity and prescription medication use in five large European countries. Pain Practice. 22(3). 359–371. 14 indexed citations

15.

Dignaß, Axel, et al.. (2021). Cost-effectiveness of tofacitinib compared with infliximab, adalimumab, golimumab, vedolizumab and ustekinumab for the treatment of moderate to severe ulcerative colitis in Germany. Journal of Medical Economics. 24(1). 279–290. 10 indexed citations

16.

Mamolo, Carla, et al.. (2021). An indirect comparison between bosutinib, nilotinib and dasatinib in first-line chronic phase chronic myeloid leukemia. Current Medical Research and Opinion. 37(5). 801–809. 7 indexed citations

17.

Duffin, Kristina Callis, Andrew G. Bushmakin, Joseph C. Cappelleri, Lotus Mallbris, & Carla Mamolo. (2019). A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies. BMC Dermatology. 19(1). 8–8. 9 indexed citations

18.

Stelljes, Matthias, Yun Su, Kyle Fahrbach, et al.. (2017). Indirect Treatment Comparison (ITC) of Inotuzumab Ozogamicin (InO) and Blinatumomab (Blina) for Relapsed or Refractory (RR) Acute Lymphoblastic Leukemia (ALL). Blood. 130. 2558–2558. 1 indexed citations

19.

Yarlas, Aaron, Martha Bayliss, Joseph C. Cappelleri, et al.. (2017). Psychometric validation of the SF-36® Health Survey in ulcerative colitis: results from a systematic literature review. Quality of Life Research. 27(2). 273–290. 37 indexed citations

20.

Althof, Stanley E., Michael M. Berner, Irwin Goldstein, et al.. (2010). Interrelationship of Sildenafil Treatment Effects on the Physiological and Psychosocial Aspects of Erectile Dysfunction of Mixed or Organic Etiology. The Journal of Sexual Medicine. 7(9). 3170–3178. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact